HomeQuestion

How would you treat CML and CLL that occurred together?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In treatment naive CLL without del(17p)/TP53, will the recent interim analysis of fixed duration acalabrutinib plus venetoclax +/- obinutuzumab vs chemoimmunotherapy in the AMPLIFY trial change your practice?

In patients with CML who are receiving 1st line TKI with good molecular response, are you continuing therapy or switching to asciminib based on the ASC4FIRST data?

Would you give GO and/or a FLT3 inhibitor for patients with AML with t(8;21) and FLT3-ITD low in addition to 7+3?

How do you manage ocular hemorrhages while on acalabrutinib for CLL?

How does the CLL17 trial presented at ASH 2025 change current practice guidelines?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

How would you treat CML and CLL that occurred together? | Mednet